Metacrine, Inc. Quarterly Return On Equity in % from Q2 2020 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Metacrine, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2020 to Q3 2022.
  • Metacrine, Inc. Return On Equity for the quarter ending September 30, 2022 was -83.8 %, a 2.74% increase year-over-year.
  • Metacrine, Inc. annual Return On Equity for 2021 was -102 %, a 95% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -83.8 +2.36 +2.74% Jul 1, 2022 Sep 30, 2022
Q2 2022 -106 -44.7 -72.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -113 -9.15 -8.84% Jan 1, 2022 Mar 31, 2022
Q4 2021 -102 +1.93K +95% Oct 1, 2021 Dec 31, 2021
Q3 2021 -86.1 -171 -202% Jul 1, 2021 Sep 30, 2021
Q2 2021 -61.4 -102 -252% Apr 1, 2021 Jun 30, 2021
Q1 2021 -104 Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.03K Oct 1, 2020 Dec 31, 2020
Q3 2020 84.6 Jul 1, 2020 Sep 30, 2020
Q2 2020 40.4 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.